Adherence to Long-term Exoskeleton Rehabilitation to Treat Lower Limb Weakness and / or Deficiencies in Adult Population
Led by Wandercraft · Updated on 2024-08-06
100
Participants Needed
1
Research Sites
N/A
Total Duration
On this page
AI-Summary
Brief Title
Who Can Participate
AI-Screening
Your Study Journey
Trial Site Locations
Research Team
How is the study designed?
Similar Trials
Frequently Asked Questions
Research Publications
AI-Summary
What this Trial Is About
This research aims to evaluate a long-term outpatient rehabilitation program using the Atalante X exoskeleton for adults with lower limb weakness or deficiencies caused by various conditions such as stroke, spinal cord injury, or neurodegenerative diseases. It addresses challenges in current rehabilitation care, like long wait times and limited accessibility, by exploring the potential benefits of robotic-assisted therapy over an extended period.
Participants will engage in at least one exoskeleton rehabilitation session weekly during a 12-month intervention phase. These sessions involve ambulatory exercises with the Atalante X device, with intensity gradually increasing over time. After the initial year, participants may choose to continue in a voluntary extension phase for an additional year, following the same rehabilitation protocol.
Throughout the study, participants will undergo assessments at the start, after 4 and 12 months, and for those in the extension phase, also at 16 and 24 months. These evaluations include tests of sitting function, walking ability, balance, muscle strength, cognitive function, and quality of life, along with monitoring of adverse events. The program also tracks detailed session data such as number of steps, session duration, and device assistance levels to understand adherence and impacts on motor and cognitive functions over time.
CONDITIONS
Brief Title
Adherence to Long-term Exoskeleton Rehabilitation to Treat Lower Limb Weakness and / or Deficiencies in Adult Population
Who Can Participate
Age: 18Years +
All Genders
Eligibility Criteria
You may qualify if you...
Patient suffering from lower limb weaknesses and/or deficiencies regardless of the cause
Adult patient 18 years old or older
Patient able to read and write in French and who have signed an informed consent form
Patient affiliated to a social security system
You will not qualify if you...
Individuals with severe spasticity of adductor muscles, hamstring, quadriceps, and triceps surae (score of 4 on the modified Ashworth scale)
Pregnant women
Individuals with a history of osteoporotic fracture and/or pathology or treatment causing secondary osteoporosis
Pressure ulcers of Grade I or higher in areas contacting the exoskeleton
Severe aphasia limiting ability to express needs or complete questionnaires
Patients with cardiac or respiratory contraindications to physical exertion
Patients unable to provide consent
Patients under legal protection
Patients participating in another study simultaneously
Patients with morphological contraindications to the use of the Atalante X exoskeleton except specific allowed joint angles (knee, ankle, hip) restrictions as per user manual guidelines
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
1
2
3
Your Study Journey
Screening
Duration - 2 to 4 weeks
Participants are screened for eligibility to participate in the trial.
1 visit (in-person)
Implementation
Duration - 1 year
Participants use the hands-free exoskeleton device to perform ambulatory exercises with gradual intensity increase during sessions lasting up to one year, with at least one session per week.
Weekly sessions with the exoskeleton
Follow-up
Duration - Up to 1 additional year
Participants may continue voluntary exoskeleton sessions following the initial intervention year, with ongoing assessments and monitoring.
Global estimates of the need for rehabilitation based on the Global Burden of Disease study 2019: a systematic analysis for the Global Burden of Disease Study 2019.